メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
藤田医科大学 ホーム
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
第４・心臓血管外科
病院局
岡崎医療センター
概要
フィンガープリント
ネットワーク
研究成果
(26)
フィンガープリント
第４・心臓血管外科が活動している研究トピックを掘り下げます。これらのトピックラベルは、この組織のメンバーの研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Medicine and Dentistry
Aneurysm
100%
Thrombosis
59%
Blood Plasma
59%
Heart Myxoma
59%
Valve Deterioration
59%
Enolase
59%
Open Heart Surgery
59%
Endovascular Aneurysm Repair
59%
Aortic Arch
59%
Diabetes Mellitus
59%
Left Ventricular Assist Device
59%
Aortic Root
59%
Pseudoaneurysm
59%
Primary Prevention
59%
Drug Therapy
59%
Revascularization
59%
4 Iodo 2,5 Dimethoxyamphetamine
59%
Coronary Artery Disease
59%
Arrhythmia
59%
Hypertrophic Obstructive Cardiomyopathy
59%
Aortic Valve
49%
Beta Chain
46%
Reoperation
44%
Aortic Root Surgery
40%
QT Dispersion
35%
Aortic Dissection
29%
Surgical Anastomosis
29%
Operative Complication
29%
Computer Assisted Tomography
29%
Descending Aorta
29%
Ascending Aorta Surgery
29%
Thoracic Aorta
29%
Surgical Infection
29%
Idiopathic Interstitial Pneumonia
29%
Muscle Resection
29%
Mitral Valve Stenosis
29%
Mitral Valve
29%
Malperfusion Syndrome
19%
Mesenteric Artery Occlusion
19%
Aortic Aneurysm
19%
Aortic Insufficiency
19%
Pseudoephedrine Plus Triprolidine
14%
Blood Stasis
14%
Ceramide Trihexoside
14%
Aortic Valve Disease
14%
Alpha-Galactosidase
14%
Long Term Survival
14%
Interventricular Septum
14%
Obstruction
14%
Ventricular Outflow Tract
14%
New York Heart Association Class
14%
Skeletal Muscle
13%
Adverse Event
13%
Patient with Diabetes
13%
Infection
13%
Ischemic Mitral Valve Regurgitation
10%
Hospital Mortality
8%
Grafting
8%
Dissecting Aneurysm
8%
Aortic Arch Surgery
8%
Brain Infarction
8%
Surgery
8%
Respiratory Failure
8%
Thoracotomy
8%
Open Surgery
8%
Polyether
8%
Shuttle Vector
8%
Alpha Chain
6%
Carbonate Dehydratase III
6%
Mitral Valve Replacement
6%
Heart Muscle Injury
6%
Enzyme Immunoassay
6%
Coronary Sinus
6%
Immunoassay Method
6%
Isoenzyme
6%
Proportional Hazards Model
6%
Diabetes
6%
Driveline Infection
6%
All Cause Mortality
6%
Postoperative Complication
6%
Blood pH
5%
Keyphrases
β-Enolase
59%
Dispersion Wave
59%
Cardiac Myxoma
59%
Creatine kinase-MM
59%
Transvenous Permanent Pacemaker Implantation
59%
Bio-Bentall
59%
Device Analysis
59%
Elastomeric Scaffold
59%
Trans-septal Approach
59%
Revascularization
59%
Primary Prevention
59%
Non-pharmacological Therapy
59%
Coronary Artery Disease
59%
Apologizing
59%
Ventricular Arrhythmia
59%
Left Atrial Myxoma
19%
Malperfusion Syndrome
19%
Pedunculated Tumor
19%
Left Ventricular Myxoma
19%
Right Superior Pulmonary Vein
19%
Mitral Valve Obstruction
19%
Robust Recommendation
19%
Cardiac Surgeons
19%
α-galactosidase Activity
19%
Pacemaking
19%
Angiokeratoma Corporis Diffusum
19%
Severe Bradycardia
19%
Glycosphingolipid Metabolism
19%
Transvenous Pacemaker
19%
Epicardial Patch
19%
Plasma beta
17%
Extended Arch
17%
Biological Valved Conduit
14%
Sewing
14%
Valve-in-valve
14%
Biological Valve
14%
Aortic Valve Disease
14%
Wave Dispersion
11%
Mitral Annuloplasty
10%
Concomitant Procedures
10%
Left Ventricular Reconstruction
10%
Impaired Left Ventricular Function
10%
M Method
10%
Ischemic Mitral Regurgitation
10%
Entry Closure
10%
Residual Dissection
10%
Microfibrous
10%
Polyether Ester Urethane
10%
Recombinant Adeno-associated Virus (rAAV)
10%
Scaffold-based
10%
Poly(ethylene oxide)
10%
Gene Vector
10%
Coaxial Electrospinning
10%
Cardiac Wall
10%
Disease Morbidity
10%
Motion Suppression
10%
Functional Mitral Stenosis
10%
Recurrent Obstruction
10%
Blood pH
5%
Proportional Hazards Regression Analysis
5%
Nonparametric Survival Analysis
5%
Coating System
5%
Aortic Cannula
5%
Azygos Vein
5%
Pharmacology, Toxicology and Pharmaceutical Science
Aneurysm
59%
Vasculotropin
59%
Adeno Associated Virus
59%
Enolase
59%
Creatine Kinase MM
59%
Infarction
17%
Macrogol
8%
Heart Infarction
8%
Polyether
8%
Ischemic Heart Disease
8%
Controlled Release
8%
Ethyl Carbamate
8%
Myocardial Disease
8%
Carbonate Dehydratase III
6%
Enzyme Immunoassay
6%
Heart Muscle Injury
6%
Immunoassay Method
6%
Isoenzyme
6%